Ownership history in MARSHALL WACE, LLP · 11 quarters on record
This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in ABEONA THERAPEUT (ABEO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 11,800 | -73,324 | -86.1% | 0.00% | $62K | $5.28 |
| 2025 Q2 | REDUCED | 85,124 | -247,276 | -74.4% | 0.00% | $484K | $5.68 |
| 2025 Q1 | ADDED | 332,400 | +281,072 | +547.6% | 0.00% | $1.6M | $4.76 |
| 2024 Q4 | REDUCED | 51,328 | -32,846 | -39.0% | 0.00% | $286K | $5.57 |
| 2024 Q3 | REDUCED | 84,174 | -44,729 | -34.7% | 0.00% | $532K | $6.32 |
| 2024 Q1 | ADDED | 128,903 | +81,047 | +169.4% | 0.00% | $935K | $7.25 |
| 2023 Q4 | ADDED | 47,856 | +34,602 | +261.1% | 0.00% | $240K | $5.01 |
| 2019 Q2 | ADDED | 13,254 | +4,168 | +45.9% | 0.00% | $63K | $119.50 |
| 2019 Q1 | REDUCED | 9,086 | -103,868 | -92.0% | 0.00% | $67K | $184.00 |
| 2018 Q4 | REDUCED | 112,954 | -185,708 | -62.2% | 0.01% | $806K | $178.50 |
As of 2025 Q4 — sorted by position size